Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Familial Mediterranean Fever
100%
Familial Mediterranean Fever Patient
42%
Colchicine
23%
Amyloidosis
20%
Giant Cell Arteritis
14%
Anakinra
13%
MEFV Gene
12%
Clinical Features
12%
Exercise-induced Leg Pain
11%
Risk Factors
10%
M694V
9%
Temporal Artery Biopsy
9%
Colchicine-resistant Familial Mediterranean Fever
8%
Colchicine Treatment
7%
Pharmacovigilance
7%
Clinical Significance
7%
Cardiac Magnetic Resonance Imaging (cMRI)
7%
Adverse Events
7%
Inflammation
6%
Familial Mediterranean Fever Attack
6%
Free Light Chains
6%
QT Dispersion
6%
Clinical Prognosis
6%
Coronary Artery Calcification
6%
Clinical Predictors
6%
COVID-19
6%
Janus Kinase Inhibitors (JAKi)
6%
Systemic Lupus Erythematosus
6%
Genotype
6%
Mediterranean Fever Gene
5%
95% Confidence Interval
5%
Cardiovascular Risk Factors
5%
AL Amyloidosis
5%
Severe Disease
5%
Israel
5%
Medicine and Dentistry
Familial Mediterranean Fever
60%
Diseases
13%
Giant-Cell Arteritis
13%
Light Chain
12%
Cardiovascular System
12%
Colchicine
12%
Amyloidosis
11%
Leg Pain
10%
Temporal Artery
9%
Immunoglobulin
9%
Inflammation
8%
AA Amyloidosis
7%
Magnetic Resonance Imaging
7%
Blood Vessel Biopsy
6%
Disease Activity
6%
Multiple Sclerosis
6%
Rheumatic Disease
6%
Arteritis
6%
Proteinuria
6%
Coronary Artery Calcification
6%
COVID-19
6%
Nephropathy
6%
Genetics
5%
Amyloid Protein
5%
Pharmacology, Toxicology and Pharmaceutical Science
Familial Mediterranean Fever
57%
Colchicine
27%
Diseases
10%
Anakinra
9%
Inflammation
9%
Interleukin 1
9%
Pharmacovigilance
7%
Rheumatoid Arthritis
7%
Inflammatory Arthritis
7%
Adverse Event
7%
Janus Kinase Inhibitor
6%
Bloodstream Infection
6%
Amyloidosis
6%
Placebo
5%
Cardiovascular Disease
5%
Systemic Lupus Erythematosus
5%
Rheumatic Disease
5%
